Ep Biocomposites Ltd vs Gulf Lloyds India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 22, 2026

Key Highlights

The Latest Trading Price of EP Biocomposites Ltd is ₹ 87 as of 22 Oct 15:30 . The P/E Ratio of EP Biocomposites Ltd is 0 as of March 2026 .The P/E Ratio of Gulf Lloyds (India) Ltd is 0 as of March 2026 . The Market Cap of EP Biocomposites Ltd is ₹ 0 crore as of March 2026 .The Market Cap of Gulf Lloyds (India) Ltd is ₹ 0 crore as of March 2026 . The Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Gulf Lloyds (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

About Gulf Lloyds (India) Ltd

Gulf Lloyds (India) Limited was originally incorporated as 'Gulf Lloyads Industrial Services (India) Private Limited' dated September 26, 2014, with the Assistant Registrar of Companies, Gujarat.
Subsequently, the name of the company was changed to Gulf Lloyds Industrial Services (India) Private Limited and again was changed to Gulf Lloyds (India) Private Limited on September 10, 2024.
Thereafter, the name of the Company was changed to Gulf Lloyds (India) Limited vide fresh Certificate of Incorporation obtained from the Central Processing Centre on January 20, 2025. The Company is engaged in providing inspection, verification, auditing, training and certification for government bodies, public sector enterprises, and private organizations engaged in infrastructure, industrial, and engineering activities and the testing services to clients operating across various industries.

FAQs for the comparison of EP Biocomposites Ltd and Gulf Lloyds (India) Ltd

Which company has a larger market capitalization, EP Biocomposites Ltd or Gulf Lloyds (India) Ltd?

Market cap of EP Biocomposites Ltd is 14 Cr while Market cap of Gulf Lloyds (India) Ltd is 19 Cr

What are the key factors driving the stock performance of EP Biocomposites Ltd and Gulf Lloyds (India) Ltd?

The stock performance of EP Biocomposites Ltd and Gulf Lloyds (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for EP Biocomposites Ltd and Gulf Lloyds (India) Ltd?

As of October 22, 2026, the EP Biocomposites Ltd stock price is INR ₹87.0. On the other hand, Gulf Lloyds (India) Ltd stock price is INR ₹29.0.

How do dividend payouts of EP Biocomposites Ltd and Gulf Lloyds (India) Ltd compare?

To compare the dividend payouts of EP Biocomposites Ltd and Gulf Lloyds (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.